| ARKR |
Ark Restaurants Corp. |
Common Stock, par value $0.01 per share |
17% |
$5,700,195 |
+$440,056 |
622,292 |
+8.4% |
Thomas A. Satterfield, Jr. |
05 Aug 2025 |
| CRIS |
Curis, Inc. |
Common Stock, par value $0.01 per share |
9.9% |
$1,512,213 |
+$358,182 |
1,035,762 |
+31% |
Thomas A. Satterfield, Jr. |
31 Mar 2025 |
| SCND |
Scientific Industries, Inc. |
Common Stock, $.05 par value |
9.9% |
$1,183,577 |
|
1,138,055 |
|
Thomas A. Satterfield, Jr. |
31 Dec 2024 |
| BCDA |
BioCardia, Inc. |
Common Stock, par value $0.001 per share |
9.9% |
$1,154,681 |
+$397,794 |
592,144 |
+53% |
Thomas A. Satterfield, Jr. |
30 Jun 2025 |
| OSTX |
OS Therapies Incorporated |
Common Stock, par value $0.001 per share |
9.4% |
$7,259,537 |
+$4,306,343 |
3,115,681 |
+146% |
Thomas A. Satterfield, Jr. |
30 Jun 2025 |
| NVNO |
enVVeno Medical Corporation |
Common Stock, $0.00001 par value per share |
9% |
$1,348,650 |
|
1,822,500 |
|
Thomas A. Satterfield, Jr. |
14 Nov 2025 |
| INTT |
inTest Corporation |
Common Stock, par value $0.01 per share |
8% |
$5,873,487 |
+$1,148,137 |
1,000,594 |
+24% |
Thomas A. Satterfield, Jr. |
30 Jun 2025 |
| CTSO |
CytoSorbents Corporation |
Common Stock, par value $0.001 per share |
6.6% |
$3,998,867 |
|
3,998,867 |
|
Thomas A. Satterfield, Jr. |
13 Jan 2025 |
| CHRS |
Coherus BioSciences, Inc. |
Common Stock, $0.0001 par value per share |
5.2% |
$5,047,992 |
|
6,009,514 |
|
Thomas A. Satterfield, Jr. |
14 Apr 2025 |
| EDSA |
Edesa Biotech, Inc. |
Common Stock, without par value |
0% |
$0 |
-$533,970 |
0 |
-100% |
Thomas A. Satterfield, Jr. |
13 Feb 2025 |